Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluations of an in-house drug resistance method for HIV-1 drug resistance using ViroSeq™ 2.0 genotyping system as a gold standard.

Journal of virological methods - 1 Apr 2013

Chaturbhuj Devidas N, Deshmukh Pravin S, Hingankar Nitin K, Siddhaarth K, Deshpande Sohan N, Sen Sourav, Kabra Sandhya, Paranjape Ramesh S, Tripathy Srikanth P

Abstract excerpt

An in-house method was evaluated for its efficiency to detect the HIV-1 drug resistance mutations. This method was compared with the ViroSeq™ Genotyping System 2.0 (Celera Diagnostics, US) a gold standard. Sixty-five stored plasma samples, previously tested for HIV-1 drug resistance using the ViroSeq™ method were used to evaluate the in-house method. Out of the sixty five plasma samples, sixty were HIV-1 positive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Base Sequence

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genotype

Share to HIV Infections

Share to HIV Reverse Transcriptase

Share to Mutation

Share to Sequence Analysis, DNA

Source

Identifiers

PMID: 23353551
DOI: 10.1016/j.jviromet.2013.01.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluations of an in-house drug resistance method for HIV-1 drug resistance using ViroSeq™ 2.0 genotyping system as a gold standard.PMID 23353551Read ↗

Evaluation of a cost effective in-house method for HIV-1 drug resistance genotyping using plasma samples.Semantic proximity Read ↗

Comparative evaluation of the ViroSeq™ HIV-1 genotyping system and an in-house method for analysis of HIV-1 drug-resistance mutations in China.Semantic proximity Read ↗

Evaluation of two human immunodeficiency virus-1 genotyping systems: ViroSeq 2.0 and an in-house method.Semantic proximity Read ↗

[The study of an in-house method for drug resistance genotyping testing on HIV-1 strains prevailing in China].Semantic proximity Read ↗

Evaluation of a Novel In-house HIV-1 Genotype Drug Resistance Assay using Clinical Samples in China.Semantic proximity Read ↗

A simple and sensitive 'in-house' method for determining genotypic drug resistance in HIV-1.Semantic proximity Read ↗

Comparison between an in-house method and the ViroSeq™ method for determining mutations for drug resistance in the HIV-1 CRF01_AE subtype circulating in China.Semantic proximity Read ↗

Performance of an in-house multiplex PCR assay for HIV-1 drug resistance testing - A cheaper alternative.Semantic proximity Read ↗

[Evaluation of the consistency of three methods for testing HIV-1 genotype drug resistance].Semantic proximity Read ↗

Next Generation Sequencing Based In-house HIV Genotyping Method: Validation ReportSemantic proximity Read ↗

Next generation sequencing based in-house HIV genotyping method: validation report.Semantic proximity Read ↗

HIV drug resistance testing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.